The Immune System in Neuroendocrine Tumors

被引：2

作者：

Thiel, A. ^{[1
]}

Ehlers, M. ^{[1
]}

Anlauf, M. ^{[2
]}

Raffel, A. ^{[3
]}

Stoecklein, N. H. ^{[3
]}

Schott, M. ^{[1
]}

机构：

[1] Univ Hosp Dusseldorf, Dept Endocrinol Diabetol & Rheumatol, D-40225 Dusseldorf, Germany

[2] Univ Hosp Dusseldorf, Inst Pathol & Endocrine Tumor Ctr, D-40225 Dusseldorf, Germany

[3] Univ Hosp Dusseldorf, Dept Gen Visceral & Pediat Surg, D-40225 Dusseldorf, Germany

来源：

HORMONE AND METABOLIC RESEARCH | 2011年 / 43卷 / 12期

关键词：

neuroendocrine malignancies; NET; tumor-immune-escape; immunoevasion; CELL LUNG-CANCER; HIGH-RISK NEUROBLASTOMA; MEDULLARY-THYROID CARCINOMA; REGULATORY T-CELLS; PHASE-I TRIAL; MHC CLASS-I; BONE-MARROW; DISEASE PROGRESSION; PERIPHERAL-BLOOD; PROGNOSTIC VALUE;

D O I：

10.1055/s-0031-1284382

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

During the last 30 years the incidence of neuroendocrine tumors has increased considerably and the overall 5-year survival rate has not changed substantially. Conventional therapeutic approaches appear to show an unsatisfactory effect in the more insidious forms of malignancies. Hence, attempts were made to direct the patient's own immune system against cancer by vaccinating against different tumor antigens. Up to date, only sporadic achievements were demonstrated in the majority cases of vaccination trials. One of the main hindrances to a successful vaccination comprises tumor-immune-escape mechanisms. This review focuses on the current knowledge concerning tumor immunoevasion strategies and the immune system in neuroendocrine tumors.

引用

页码：890 / 896

页数：7

共 50 条

[1] Immune oncology and neuroendocrine tumors
Chauhan, A.
Anthony, L.
ANNALS OF ONCOLOGY, 2017, 28 (09) : 2322 - 2323
[2] Neuroendocrine tumors of the diffuse neuroendocrine system
Gustafsson, Bjorn I.
Kidd, Mark
Modlin, Irvin M.
CURRENT OPINION IN ONCOLOGY, 2008, 20 (01) : 1 - 12
[3] Immune Checkpoint Inhibitors in Progressive Neuroendocrine Tumors
Chauhan, Aman
Anthony, Lowell
PANCREAS, 2018, 47 (03) : 335 - 335
[4] Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors
Gubbi, Sriram
Vijayvergia, Namrata
Yu, Jian Q.
Klubo-Gwiezdzinska, Joanna
Koch, Christian A.
HORMONE AND METABOLIC RESEARCH, 2022, 54 (12) : 795 - 812
[5] Neuroendocrine interactions in the immune system
Taub, Dennis D.
CELLULAR IMMUNOLOGY, 2008, 252 (1-2) : 1 - 6
[6] Analysis of the immune landscape of small bowel neuroendocrine tumors
Cives, M.
Strosberg, J.
Al Diffalha, S.
Coppola, D.
ENDOCRINE-RELATED CANCER, 2019, 26 (01) : 119 - 130
[7] Reasons for the cold immune microenvironment of neuroendocrine tumors.
de Hosson, Lotte D.
Bouma, Grietje
Kats-Ugurlu, Gursah
Bulthuis, Marian
de Vries, Elisabeth G. E.
Van Faassen, Martijn
Kema, Ido P.
Walenkamp, Anna Maria Elisabeth
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[8] Systematic Evaluation of the Immune Microenvironment of Neuroendocrine Tumors (NET)
Vesely, C.
Childs, A.
Wong, Y. N. S.
Ogunbiyi, O.
Gander, A.
Luong, T., V
Thirlwell, C.
Caplin, M.
Peggs, K.
Marafioti, T.
Quezada, S. A.
Meyer, T.
NEUROENDOCRINOLOGY, 2018, 106 : 19 - 19
[9] Immune landscape and progress in immunotherapy for pituitary neuroendocrine tumors
Guo, Xiaopeng
Yang, Yiying
Qian, Zhihong
Chang, Mengqi
Zhao, Yuanli
Ma, Wenbin
Wang, Yu
Xing, Bing
CANCER LETTERS, 2024, 592
[10] Hereditary neuroendocrine tumors of the gastroenteropancreatic system
Martin Anlauf
Nele Garbrecht
Juliane Bauersfeld
Anja Schmitt
Tobias Henopp
Paul Komminoth
Philipp U. Heitz
Aurel Perren
Günter Klöppel
Virchows Archiv, 2007, 451 : 29 - 38

← 1 2 3 4 5 →